Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
CRISPR-gentherapie toont duurzame klinische stabiliteit bij erfelijke ATTR-polyneuropathie
jan 2026